Related references
Note: Only part of the references are listed.I.p.-injected cationic liposomes are retained and accumulate in peritoneally disseminated tumors
Rie Ando-Matsuoka et al.
JOURNAL OF CONTROLLED RELEASE (2022)
HIV persistence in lymph nodes
Riddhima Banga et al.
CURRENT OPINION IN HIV AND AIDS (2021)
Intraperitoneal Route of Drug Administration: Should it Be Used in Experimental Animal Studies?
Abdullah Al Shoyaib et al.
PHARMACEUTICAL RESEARCH (2020)
Nano- and microcrystals of griseofulvin subcutaneously administered to rats resulted in improved bioavailability and sustained release
Kalle Sigfridsson et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2019)
Sustained release and improved bioavailability in mice after subcutaneous administration of griseofulvin as nano- and microcrystals
Kalle Sigfridsson et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Therapeutic delivery to the peritoneal lymphatics: Current understanding, potential treatment benefits and future prospects
Ali Sarfarazi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Lymphatic Uptake of Liposomes after Intraperitoneal Administration Primarily Occurs via the Diaphragmatic Lymphatics and is Dependent on Liposome Surface Properties
Given Lee et al.
MOLECULAR PHARMACEUTICS (2019)
Nanocrystal Technology as a Strategy to Improve Drug Bioavailability and Antitumor Efficacy for the Cancer Treatment
Mingxue Fan et al.
CURRENT PHARMACEUTICAL DESIGN (2018)
Pharmaceutical nanocrystals: production by wet milling and applications
Maria Malamatari et al.
DRUG DISCOVERY TODAY (2018)
The epithelial-to-mesenchymal transition induced by tumor-associated macrophages confers chemoresistance in peritoneally disseminated pancreatic cancer
Kazuya Kuwada et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Nanocrystals Technology for Improving Bioavailability of Poorly Soluble Drugs: A Mini-Review
Yuqi Zhou et al.
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY (2017)
Nanomedicine-based intraperitoneal therapy for the treatment of peritoneal carcinomatosis - Mission possible?
George R. Dakwar et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Probing adsorption of DSPE-PEG2000 and DSPE-PEG5000 to the surface of felodipine and griseofulvin nanocrystals
Hanna A. Rydberg et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
Stabilizing Agents for Drug Nanocrystals: Effect on Bioavailability
Annika Tuomela et al.
PHARMACEUTICS (2016)
Nano-chemotherapeutics: Maximising lymphatic drug exposure to improve the treatment of lymph-metastatic cancers
Gemma M. Ryan et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Drug nanocrystals in the commercial pharmaceutical development process
Jan P. Moeschwitzer
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
PEGylated polylysine dendrimers increase lymphatic exposure to doxorubicin when compared to PEGylated liposomal and solution formulations of doxorubicin
Gemma M. Ryan et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Optimization of Drug Delivery Systems for Intraperitoneal Therapy to Extend the Residence Time of the Chemotherapeutic Agent
L. De Smet et al.
SCIENTIFIC WORLD JOURNAL (2013)
An injectable depot system for sustained intraperitoneal chemotherapy of ovarian cancer results in favorable drug distribution at the whole body, peritoneal and intratumoral levels
Payam Zahedi et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Hyaluronic acid-based hydrogel for regional delivery of paclitaxel to intraperitoneal tumors
Gaurav Bajaj et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Nanosizing for oral and parenteral drug delivery: A perspective on formulating poorly-water soluble compounds using wet media milling technology
Elaine Merisko-Liversidge et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
Effect of liposome size on peritoneal retention and organ distribution after intraperitoneal injection in mice
N. Mirahmadi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Peritoneal retention of liposomes: Effects of lipid composition, PEG coating and liposome charge
S. Dadashzadeh et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Pharmaceutical nanocrystals by nanomilling: critical process parameters, particle fracturing and stabilization methods
Leena Peltonen et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2010)
Drug Delivery Systems for Intraperitoneal Therapy
Gaurav Bajaj et al.
PHARMACEUTICAL RESEARCH (2010)
Early integration of pharmacokinetic and dynamic reasoning is essential for optimal development of lead compounds: strategic considerations
Johan Gabrielsson et al.
DRUG DISCOVERY TODAY (2009)
Effects of carrier on disposition and antitumor activity of intraperitoneal paclitaxel
Max Tsai et al.
PHARMACEUTICAL RESEARCH (2007)
Developing early formulations: Practice and perspective
Ping Li et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
Biodegradable polymeric microspheres and nanospheres for drug delivery in the peritoneum
DS Kohane et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2006)
Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation
CM Keck et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2006)
Pharmaceutical evaluation of early development candidates the 100 mg-approach
S Balbach et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2004)
Transmission, acute HIV-1 infection and the quest for strategies to prevent infection
M Pope et al.
NATURE MEDICINE (2003)
Intraperitoneal administration of doxorubicin encapsulating liposomes against peritoneal dissemination
Y Sadzuka et al.
TOXICOLOGY LETTERS (2000)
Share Paper
